Introduction: The GENLISA ELISA kits are used for assessing the specific biomarker in samples analytes which may be serum, plasma and cell culture supernatant as validated with the kit. The kit employs a sandwich ELISA technique which leads to a higher specificity and increased sensitivity compared to conventional competitive ELISA kits which employ only one antibody. Intended Use: The GENLISA Human Anti-SARS-CoV-2 (Covid-19) IgG to spike RBD Omicron Variant (B.1.1.529) Quantitative TITRATION ELISA kit is used as an analytical tool for quantitative estimation of Anti-SARS-CoV-2 (2019-nCoV) spike RBD antibodies in Human serum and plasma. Principle: The method employs indirect sandwich ELISA technique. SARS-CoV-2 Spike RBD Omicron Variant (B.1.1.529) protein is pre-coated onto microwells. Samples and standards are pipetted into microwells and Antibodies to Human Anti-SARS-CoV-2 (2019-nCoV) present in the sample are bound by the protein antigen. After incubation the wells are washed and followed by addition of HRP-conjugated Detection IgG Antibody into each well and incubated to form a complex. After washing microwells in order to remove any non-specific binding, the substrate solution (TMB) is added to microwells and color develops proportionally to the amount of AntiHuman Anti-SARS-CoV-2 (2019-nCoV) in the sample. Color development is then stopped by addition of stop solution. Absorbance is measured at 450 nm.
GENLISA™ Human Anti-SARS-CoV-2 (Covid-19) IgG to spike RBD Omicron Variant (B.1.1.529) Quantitative TITRATION ELISA
SKU: KBVH015-43
Rs 28,800.00
ELISA for quantitative estimation of Anti SARS-CoV-2 IgG antibodies to Spike RBD protein of the Omicron variant in human serum and plasma samples. The assay kit contains a SARS-CoV-2 Spike RBD Omicron Variant (B.1.1.529) protein Coated Microtiter Plate and Anti-SARS-CoV-2 Spike RBD Antibody (Omicron Reactive) as Standards in the kit. Why the RBD protein The COVID-19 Omicron variant is by far the most divergent variant characterized by a high number of mutations in the spike protein. Several mutations (e.g., N501Y, P681H) have been identified in previous variants and are associated with increased transmissibility, immune escape, or other properties. There are a total of 30 amino acid changes: among which 15 are located in the RBD region of the virus.
Availability: 2 – 3 Days | Pack Size: 1 x 96 wells
Additional information
| Calibration Range | 62.5 – 2000 ng/ml |
|---|---|
| Sensitivity | 30 ng/ml |
| Regulatory Status | For Research Use Only |
| Research Area | COVID-19 |
